(Q34248654)

31 July 2017

title

The Diagnosis and Treatment of Ductal Carcinoma In Situ of the Breast (English)

1 reference

31 July 2017

1 reference

Eleanor E. R. Harris

1

1 reference

31 July 2017

Lawrence J. Solin

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

78-95

1 reference

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Flow cytometric and histological analysis of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Follow-up of two treatment modalities for ductal cancer in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

The influence of margin width on local control of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Classification of ductal carcinoma in situ by image analysis of calcifications from digital mammograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Current concepts in the detection and treatment of the earliest of the early breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Natural history of in situ breast cancer in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Axillary node dissection in ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Preservation of cosmesis with low complication risk after conservative surgery and radiotherapy for ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Conservation therapy for breast cancers other than infiltrating ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

A prognostic index for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Predictors of local recurrence following excision alone for ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Ductal carcinoma in situ of the male breast. Analysis of 31 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Ductal carcinoma in situ of the male breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Time trend of female breast carcinoma In Situ by race and histology in Connecticut, U.S.A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Subcutaneous mastectomy for primary breast cancer and ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

Assessment of Hormone Dependence of Comedo Ductal Carcinoma In Situ of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2000.99091.X

10.1046/J.1524-4741.2000.99091.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference